vs
Side-by-side financial comparison of NORTECH SYSTEMS INC (NSYS) and PCB BANCORP (PCB). Click either name above to swap in a different company.
NORTECH SYSTEMS INC is the larger business by last-quarter revenue ($30.3M vs $29.2M, roughly 1.0× PCB BANCORP). On growth, PCB BANCORP posted the faster year-over-year revenue change (11.3% vs 5.9%). PCB BANCORP produced more free cash flow last quarter ($24.4M vs $5.5M). Over the past eight quarters, PCB BANCORP's revenue compounded faster (10.4% CAGR vs -5.9%).
Nortech Systems Inc is a global electronics manufacturing services provider. It delivers end-to-end solutions covering product design, prototyping, full-scale production, and supply chain management for clients operating in medical technology, industrial automation, aerospace and defense, and transportation sectors. It specializes in high-reliability, regulatory-compliant electronic components and assemblies tailored to strict industry standards.
PCB Bank is an American community bank that focuses on the Korean-American community based in California and offers commercial banking services. It has branches in 8 states and is the third largest Korean American Bank after Bank of Hope and Hanmi Bank.
NSYS vs PCB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $30.3M | $29.2M |
| Net Profit | $897.0K | — |
| Gross Margin | 16.7% | — |
| Operating Margin | 3.0% | 45.0% |
| Net Margin | 3.0% | — |
| Revenue YoY | 5.9% | 11.3% |
| Net Profit YoY | 160.7% | — |
| EPS (diluted) | $0.32 | $0.65 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.3M | $29.2M | ||
| Q3 25 | $30.5M | $30.4M | ||
| Q2 25 | $30.7M | $29.3M | ||
| Q1 25 | $26.9M | $26.9M | ||
| Q4 24 | $28.6M | $26.2M | ||
| Q3 24 | $31.4M | $25.3M | ||
| Q2 24 | $33.9M | $24.2M | ||
| Q1 24 | $34.2M | $23.9M |
| Q4 25 | $897.0K | — | ||
| Q3 25 | $-146.0K | $11.4M | ||
| Q2 25 | $313.0K | $9.1M | ||
| Q1 25 | $-1.3M | $7.7M | ||
| Q4 24 | $-1.5M | — | ||
| Q3 24 | $-739.0K | $7.8M | ||
| Q2 24 | $157.0K | $6.3M | ||
| Q1 24 | $765.0K | $4.7M |
| Q4 25 | 16.7% | — | ||
| Q3 25 | 16.5% | — | ||
| Q2 25 | 15.8% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 12.2% | — | ||
| Q2 24 | 13.6% | — | ||
| Q1 24 | 15.9% | — |
| Q4 25 | 3.0% | 45.0% | ||
| Q3 25 | 3.1% | 52.3% | ||
| Q2 25 | 2.4% | 43.3% | ||
| Q1 25 | -6.0% | 40.2% | ||
| Q4 24 | -4.3% | 39.3% | ||
| Q3 24 | -1.5% | 42.2% | ||
| Q2 24 | 1.0% | 36.3% | ||
| Q1 24 | 3.4% | 27.2% |
| Q4 25 | 3.0% | — | ||
| Q3 25 | -0.5% | 37.5% | ||
| Q2 25 | 1.0% | 31.0% | ||
| Q1 25 | -4.9% | 28.8% | ||
| Q4 24 | -5.2% | — | ||
| Q3 24 | -2.4% | 30.8% | ||
| Q2 24 | 0.5% | 25.9% | ||
| Q1 24 | 2.2% | 19.6% |
| Q4 25 | $0.32 | $0.65 | ||
| Q3 25 | $-0.05 | $0.78 | ||
| Q2 25 | $0.12 | $0.62 | ||
| Q1 25 | $-0.48 | $0.53 | ||
| Q4 24 | $-0.51 | $0.46 | ||
| Q3 24 | $-0.27 | $0.52 | ||
| Q2 24 | $0.05 | $0.43 | ||
| Q1 24 | $0.26 | $0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $207.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $34.5M | $390.0M |
| Total Assets | $71.9M | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $207.1M | ||
| Q3 25 | $1.3M | $369.5M | ||
| Q2 25 | $652.0K | $263.6M | ||
| Q1 25 | $1.2M | $214.3M | ||
| Q4 24 | $916.0K | $198.8M | ||
| Q3 24 | $1.2M | $193.1M | ||
| Q2 24 | $1.5M | $177.6M | ||
| Q1 24 | $4.0M | $239.8M |
| Q4 25 | $34.5M | $390.0M | ||
| Q3 25 | $33.4M | $384.5M | ||
| Q2 25 | $33.4M | $376.5M | ||
| Q1 25 | $32.8M | $370.9M | ||
| Q4 24 | $34.0M | $363.8M | ||
| Q3 24 | $35.7M | $362.3M | ||
| Q2 24 | $36.1M | $353.5M | ||
| Q1 24 | $36.0M | $350.0M |
| Q4 25 | $71.9M | $3.3B | ||
| Q3 25 | $74.8M | $3.4B | ||
| Q2 25 | $74.8M | $3.3B | ||
| Q1 25 | $73.5M | $3.2B | ||
| Q4 24 | $72.4M | $3.1B | ||
| Q3 24 | $77.0M | $2.9B | ||
| Q2 24 | $76.3M | $2.9B | ||
| Q1 24 | $75.5M | $2.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.6M | $26.6M |
| Free Cash FlowOCF − Capex | $5.5M | $24.4M |
| FCF MarginFCF / Revenue | 18.0% | 83.6% |
| Capex IntensityCapex / Revenue | 0.5% | 7.5% |
| Cash ConversionOCF / Net Profit | 6.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $46.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $26.6M | ||
| Q3 25 | $-92.0K | $16.4M | ||
| Q2 25 | $157.0K | $4.9M | ||
| Q1 25 | $-2.9M | $2.3M | ||
| Q4 24 | $793.0K | $39.0M | ||
| Q3 24 | $-1.6M | $11.9M | ||
| Q2 24 | $-4.3M | $14.6M | ||
| Q1 24 | $2.8M | $8.2M |
| Q4 25 | $5.5M | $24.4M | ||
| Q3 25 | $-242.0K | $16.2M | ||
| Q2 25 | $58.0K | $3.8M | ||
| Q1 25 | $-3.2M | $1.6M | ||
| Q4 24 | $503.0K | $34.9M | ||
| Q3 24 | $-1.6M | $11.9M | ||
| Q2 24 | $-4.6M | $12.8M | ||
| Q1 24 | $2.1M | $6.0M |
| Q4 25 | 18.0% | 83.6% | ||
| Q3 25 | -0.8% | 53.2% | ||
| Q2 25 | 0.2% | 13.1% | ||
| Q1 25 | -11.9% | 6.0% | ||
| Q4 24 | 1.8% | 133.2% | ||
| Q3 24 | -5.2% | 46.8% | ||
| Q2 24 | -13.5% | 53.1% | ||
| Q1 24 | 6.1% | 25.2% |
| Q4 25 | 0.5% | 7.5% | ||
| Q3 25 | 0.5% | 0.8% | ||
| Q2 25 | 0.3% | 3.7% | ||
| Q1 25 | 1.0% | 2.8% | ||
| Q4 24 | 1.0% | 15.5% | ||
| Q3 24 | 0.1% | 0.1% | ||
| Q2 24 | 0.8% | 7.3% | ||
| Q1 24 | 2.2% | 9.3% |
| Q4 25 | 6.25× | — | ||
| Q3 25 | — | 1.44× | ||
| Q2 25 | 0.50× | 0.54× | ||
| Q1 25 | — | 0.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | -27.30× | 2.33× | ||
| Q1 24 | 3.70× | 1.76× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NSYS
| Medical Imaging | $11.4M | 37% |
| Medical Device | $8.0M | 26% |
| Industrial | $7.3M | 24% |
| Aerospace And Defense | $3.7M | 12% |
PCB
Segment breakdown not available.
